验证码已发送至您的邮箱或手机,请查收。
Phase II Discontinued
An integrase inhibitor potentially for the treatment of HIV infection and HBV infection.
Research Code IBE-5
CAS No.
251320-66-8(1
5-Dicaffeoylquininic acid)
Adenovirus type 5 vector based ebola virus disease vaccine
Approved
A vaccine used to prevent Ebola virus disease (EVD).
Research Code Ad5-EBOV
CAS No.
Phase I Active
A serotonin and norepinephrine reuptake inhibitor potentially for the treatment of depression.
Research Code S-071031B
CAS No.
1417918-12-7(S-071031B)
Research Code
CAS No.
642407-63-4(Iptakalim Hydrochloride)
642407-44-1(Iptakalim)
Phase II Active
A μ-opioid receptor (MOR1) agonist potentially for the treatment of opioid dependency.
Research Code
CAS No.
503186-26-3(Thionorphine Hydrochloride)
742060-74-8(Thenorphine)
Research Code 7903
CAS No.
82351-05-1(氯桂丁胺)
Phase III Active
Research Code ADX-102; NS-2; NS-2-Aldeyra
CAS No.
916056-79-6(NS-2)
Phase III Active
Research Code
CAS No.
99-20-7(D-Trehalose)
Research Code CG-100649
CAS No.
301692-76-2(Polmacoxib)
Phase II Active
Research Code CG400549; ERCG-0549; CG-400549; CG-0549
CAS No.
934628-27-0(CG-400549)
Phase II Active
A histone deacetylase (HDAC) inhibitor potentially for the treatment of solid tumors.
Research Code CG200745-PPA
CAS No.
936221-33-9(CG-200745)
Research Code LY-573144; COL-144
CAS No.
613677-28-4(Lasmiditan Hydrochloride)
439239-90-4(Lasmiditan)
Phase I Discontinued
Research Code rBPI-23
CAS No.
Phase II Active
Research Code XOMA-358; XOMA-247; XPA.15.247
CAS No.
Research Code XOMA-3AB
CAS No.
Phase II Discontinued
Research Code CHIR-12.12; HCD-122
CAS No.
903512-50-5
Research Code XOMA-629; XMP-629
CAS No.
316805-65-9(XMP-629)
Phase III Active
Research Code AB-7; S-78989; XMA-005.2; XOMA-052
CAS No.
1129435-60-4
Successful modification
Please choose to cancel the drug